Form D · Pharmaceuticals
MedAvail Holdings, Inc.
Phoenix, AZ · CIK 0001402479
Offering snapshot reported Apr 19, 2022 · SEC filing
- Reported sold
- $40M Offering amount: $79.4M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 19, 2022 | Initial | $39,999,996 | No comparison | 9 | SEC filing |
| Feb 6, 2014 | Initial | $4,735,000 | No comparison | 32 | SEC filing |
| Jul 11, 2012 | Initial | $5,600,000 | No comparison | 55 | SEC filing |
| Feb 24, 2012 | Initial | $725,000 | No comparison | 6 | SEC filing |
| Jun 15, 2011 | Initial | $423,000 | No comparison | 10 | SEC filing |
| Mar 8, 2011 | Initial | $1,430,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2M
- Finders' fees
- $0
- Form D file number
- 021-442582
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cowen and Company, LLC | 7616 |
Source: Form D, filed Apr 19, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Buzz Aldrin | Director |
| Louis Aronne | Director |
| J.B. Bernstein | Director, Executive, Promoter |
| Carlon Colker, Md, Facn | Executive |
| Carl De Freitas | Director, Executive |
| Peter Diamandis | Director |
| Mark Edward Doerr | Director, Executive |
| Robert C. Faulkner | Director |
| Gerald Gradwell | Director |
| Robert J. Hariri | Director |
| Paul D. Johnson | Director |
| Michael R. Kramer | Director |
| Peter Levy | Executive |
| Georgette Mathers | Director |
| Laurie Mc Graw | Director |
| Ramona Seabaugh | Executive |
| Sapna Srivastava | Director |
| Glen Stettin | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4720 E Cotton Gin Loop Suite 220
Phoenix, AZ, 85040
Phoenix, AZ, 85040